X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (79) 79
index medicus (77) 77
cancer (58) 58
oncology (54) 54
middle aged (50) 50
life sciences (49) 49
aged (48) 48
male (48) 48
radiotherapy (43) 43
female (42) 42
adult (38) 38
combined modality therapy (37) 37
chemotherapy (34) 34
surgery (32) 32
treatment outcome (22) 22
antineoplastic combined chemotherapy protocols - therapeutic use (21) 21
neoplasm staging (21) 21
carcinoma (20) 20
radiation-therapy (19) 19
aged, 80 and over (18) 18
care and treatment (18) 18
disease-free survival (18) 18
rectal neoplasms (17) 17
rectal neoplasms - pathology (16) 16
rectal neoplasms - radiotherapy (16) 16
adenocarcinoma (15) 15
randomized-trial (15) 15
chemoradiotherapy (14) 14
chemotherapy, adjuvant (14) 14
hematology, oncology and palliative medicine (14) 14
rectal neoplasms - surgery (14) 14
research (14) 14
abridged index medicus (13) 13
chemoradiation (13) 13
fluorouracil (13) 13
fluorouracil - administration & dosage (13) 13
neoplasm recurrence, local (13) 13
radiotherapy dosage (13) 13
rectal cancer (13) 13
rectal neoplasms - drug therapy (13) 13
rectal neoplasms - mortality (13) 13
follow-up studies (12) 12
radiation therapy (12) 12
radiology, nuclear medicine & medical imaging (12) 12
adenocarcinoma - radiotherapy (11) 11
esophageal cancer (11) 11
neoadjuvant therapy (11) 11
prospective studies (11) 11
rectal neoplasms - therapy (11) 11
survival (11) 11
survival analysis (11) 11
total mesorectal excision (11) 11
adenocarcinoma - surgery (10) 10
cancer therapies (10) 10
health aspects (10) 10
preoperative radiotherapy (10) 10
prognosis (10) 10
randomized controlled trials as topic (10) 10
colorectal cancer (9) 9
esophageal neoplasms - radiotherapy (9) 9
irradiation (9) 9
phase-iii trial (9) 9
radiation (9) 9
survival rate (9) 9
antineoplastic combined chemotherapy protocols (8) 8
france (8) 8
medicine & public health (8) 8
oncology, experimental (8) 8
quality of life (8) 8
therapy (8) 8
adenocarcinoma - drug therapy (7) 7
adenocarcinoma - mortality (7) 7
adjuvant treatment (7) 7
antineoplastic agents - therapeutic use (7) 7
clinical trials (7) 7
esophageal neoplasms - drug therapy (7) 7
leucovorin - administration & dosage (7) 7
medicine, general & internal (7) 7
patients (7) 7
prostate cancer (7) 7
prostatic neoplasms - surgery (7) 7
radiotherapy, adjuvant (7) 7
risk factors (7) 7
time factors (7) 7
analysis (6) 6
antineoplastic agents (6) 6
cancer patients (6) 6
cisplatin (6) 6
cisplatin - administration & dosage (6) 6
colon (6) 6
follow-up (6) 6
leucovorin (6) 6
local recurrence (6) 6
lymphatic metastasis (6) 6
metastasis (6) 6
proportional hazards models (6) 6
prostatic neoplasms - radiotherapy (6) 6
rectal neoplasms - diagnosis (6) 6
rectum (6) 6
retrospective studies (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9858, pp. 2018 - 2027
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2006, Volume 355, Issue 11, pp. 1114 - 1123
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 2, pp. 184 - 190
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2009, Volume 360, Issue 24, pp. 2516 - 2527
A current standard treatment for locally advanced prostate cancer is external-beam radiotherapy combined with 3 years of androgen suppression. Adverse events,... 
PHASE-III TRIAL | DEPRIVATION THERAPY | IRRADIATION | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | EORTC | RANDOMIZED-TRIAL | QUALITY-OF-LIFE | RADIOTHERAPY | RADIATION-THERAPY | ADJUVANT | Anilides - therapeutic use | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Anilides - adverse effects | Humans | Middle Aged | Male | Gonadotropin-Releasing Hormone - analogs & derivatives | Flutamide - adverse effects | Treatment Failure | Aged, 80 and over | Adult | Flutamide - therapeutic use | Prostatic Neoplasms - drug therapy | Drug Administration Schedule | Proportional Hazards Models | Combined Modality Therapy | Prostatic Neoplasms - mortality | Disease-Free Survival | Tosyl Compounds - adverse effects | Heart Diseases - mortality | Tosyl Compounds - therapeutic use | Quality of Life | Radiotherapy, Conformal - adverse effects | Aged | Androgen Antagonists - administration & dosage | Androgen Antagonists - adverse effects | Nitriles - adverse effects | Nitriles - therapeutic use | Heart attacks | Medical treatment | Mortality | Radiation therapy | Prostate cancer | Cancer therapies | Quality of life | Index Medicus | Abridged Index Medicus | Androgen Antagonists | Anilides | Life Sciences | Prostatic Neoplasms | Flutamide | Heart Diseases | Radiotherapy, Conformal | Gonadotropin-Releasing Hormone | Nitriles | Tosyl Compounds | Cancer
Journal Article
Radiotherapy and Oncology, ISSN 0167-8140, 04/2014, Volume 111, Issue 1, pp. 120 - 125
The purpose of this study was to describe the pattern of nodal relapse with F-fluoro-choline (FCH) Positron Emission Tomography/Computerized Tomography... 
18Fluoro-choline | Nodal relapse | Whole pelvic radiotherapy | Prostate cancer | PET/CT | Life Sciences | Bioengineering | Nuclear medicine
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2008, Volume 26, Issue 3, pp. 508 - 509
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2008, Volume 26, Issue 3, pp. 508 - 509
Journal Article
Journal Article